<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01088854</url>
  </required_header>
  <id_info>
    <org_study_id>upeclin/HC/FMB-Unesp-30</org_study_id>
    <nct_id>NCT01088854</nct_id>
  </id_info>
  <brief_title>Acute Effect of Continuous Positive Airway Pressure in Heart Failure</brief_title>
  <official_title>Acute Effect of Continuous Positive Airway Pressure on Left Ventricular Diastolic Function and Exercise Tolerance in Compensated Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UPECLIN HC FM Botucatu Unesp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>UPECLIN HC FM Botucatu Unesp</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute effects of CPAP on diastolic function in patients with compensated heart failure (CHF)
      are unknown. The investigators hypothesized that acutely CPAP improves diastolic function,
      which is associated with increases exercise tolerance.

      Objective: To evaluate the acute effects of CPAP on functional capacity and diastolic indices
      of patients with CHF. This is a randomized trial including 44 patients with compensated heart
      failure (functional classes II or III, NYHA). Patients will be allocated in CPAP(CPAP with
      10cmH2O) or simulated CPAP (null pressure) after computed randomization, in a 1:1 ratio. All
      subjects shall complete a 6-minute walk test (6MWT) before and after CPAP (30 minutes; 10 cm
      H2O pressure). Doppler-echocardiogram will be performed before and at the end of CPAP.
      Wilcoxon or paired t tests were used to compare results, with significance level at p &lt; 0.05.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>improvement of isovolumetric relaxation time</measure>
    <time_frame>30 minutes</time_frame>
    <description>Doppler-derived isovolumetric time will be measured before and after intervention (CPAP). A decreasing in isovolumetric time after CPAP will be interpretated as an improvement in myocardial relaxation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>walk distance in the walk-test-six-minute (WT6M)</measure>
    <time_frame>30 minutes</time_frame>
    <description>subjects will be tested before and after procedure (CPAP). An increasing distance after procedure will be interpretated as improved tolerance to exercise</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>positive airway pressure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>unique session of 30-minute of continuous airway positive pressure</description>
    <arm_group_label>positive airway pressure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  functional class II or III (NYHA)heart failure

          -  agreement to participate in the study

          -  absence of acute exacerbation of dyspnea

          -  intact upper airway

        Exclusion Criteria:

          -  valvular heart disease

          -  chest pain or unstable angina

          -  acute myocardial infarction in the prior month

          -  uncontrolled hypertension

          -  atrial fibrillation or other arrhythmias

          -  acute infection

          -  orthopedic limitations

          -  intolerance to CPAP mask
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beatriz B Matsubara, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Full Professor Botucatu Medical School; UNESP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UPECLIN - Botucatu Medical School</name>
      <address>
        <city>Botucatu</city>
        <state>Sao Paulo</state>
        <zip>18618-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Bradley TD, Logan AG, Kimoff RJ, Sériès F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Tomlinson G, Floras JS; CANPAP Investigators. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005 Nov 10;353(19):2025-33.</citation>
    <PMID>16282177</PMID>
  </reference>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2009</study_first_submitted>
  <study_first_submitted_qc>March 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2010</study_first_posted>
  <last_update_submitted>June 19, 2015</last_update_submitted>
  <last_update_submitted_qc>June 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UPECLIN HC FM Botucatu Unesp</investigator_affiliation>
    <investigator_full_name>Marjory Bussoni</investigator_full_name>
    <investigator_title>mester</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

